Ubs Group Ag Nexalin Technology, Inc. Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 4,168 shares of NXL stock, worth $6,168. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,168

Holding current value

$6,168

% of portfolio

0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.3 - $1.4 $1,250 - $5,835	4,168 New	4,168 $5,000
Q2 2023 Aug 11, 2023	SELL	$0.72 - $0.92 $833 - $1,065	-1,158 Reduced 36.67%	2,000 $1,000
Q1 2023 May 12, 2023	SELL	$0.75 - $1.22 $932 - $1,516	-1,243 Reduced 28.24%	3,158 $2,000
Q4 2022 Feb 08, 2023	BUY	$0.74 - $2.39 $190 - $616	258 Added 6.23%	4,401 $3,000
Q3 2022 Nov 10, 2022	BUY	$1.23 - $2.25 $5,095 - $9,321	4,143 New	4,143 $4,000

Others Institutions Holding NXL

# of Institutions

Shares Held

63.5K

Call Options Held

Put Options Held

Geode Capital Management, LLC Boston, MA

38.9K
Shares

$57,521
0.0% of portfolio
Jane Street Group, LLC New York, NY

11.3K
Shares

$16,737
0.0% of portfolio
Tower Research Capital LLC (Trc) New York, NY

9.08K
Shares

$13,436
0.0% of portfolio
Wells Fargo & Company San Francisco, CA

44
Shares

$65
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Nexalin Technology, Inc.

Ticker NXL
Exchange
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,279,960
Market Cap $10.8M

More about NXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account